Compared to the normal prostate tissues or primary prostate tumors, the mRNA levels of DVL3, MAPK9, and CTNNB1 are higher in metastatic prostate tumors while the mRNA level of ROR2 is lower in metastatic prostate tumors (Figure 6). This evidence concerns the gene CTNNB1 and prostate neoplasm.